2022
DOI: 10.1016/j.hrthm.2022.03.759
|View full text |Cite
|
Sign up to set email alerts
|

Ca-536-01 Pulsed-Field Ablation Based Pulmonary Vein Isolation: Acute Safety and Efficacy in a Multi-Center Real World Scenario

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Venous blood samples before and after successful PVI showed an increase of hsTropI and S100B plasma concentration in PFA (S100B: 34±2 to 62±6 pg/mL, hsTropI: 11±2 to 429±87 pg/mL; P<0.001) and CBA (S100B: 38±5 to 106±8 pg/mL, hsTropI: 5±1 to 168±32 pg/mL; P<0.001). The release of S100B was 2 to 3 times lower in PFA (28±6; 25 [9-35] pg/mL) than in CBA (68±7, 54 [37-92] pg/mL; P<0.001), whereas the increase of hsTropI was 3 Heart rate was evaluated in patients in sinus rhythm from resting ECG before and after PVI in a cohort of patients with paroxysmal atrial fibrillation. Heart rates after PFA-PVI were unchanged (from 64±10 to 64±10/ minute; P=0.989) but increased after CBA-PVI (from 61±10 to 71±9/minute; P<0.001).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Venous blood samples before and after successful PVI showed an increase of hsTropI and S100B plasma concentration in PFA (S100B: 34±2 to 62±6 pg/mL, hsTropI: 11±2 to 429±87 pg/mL; P<0.001) and CBA (S100B: 38±5 to 106±8 pg/mL, hsTropI: 5±1 to 168±32 pg/mL; P<0.001). The release of S100B was 2 to 3 times lower in PFA (28±6; 25 [9-35] pg/mL) than in CBA (68±7, 54 [37-92] pg/mL; P<0.001), whereas the increase of hsTropI was 3 Heart rate was evaluated in patients in sinus rhythm from resting ECG before and after PVI in a cohort of patients with paroxysmal atrial fibrillation. Heart rates after PFA-PVI were unchanged (from 64±10 to 64±10/ minute; P=0.989) but increased after CBA-PVI (from 61±10 to 71±9/minute; P<0.001).…”
mentioning
confidence: 99%
“…Patients were included consecutively after study approval by the ethics committee in Hamburg (REGIS-TRATION: URL: https://www.clinicaltrials.gov; TRUST registry, NCT05521451, 2020-10066-BO). Blood was obtained in patients undergoing a first PVI using the PFA pentaspline catheter (Farawave, Farapulse, Boston Scientific) 3 or CBA (Arctic Front Advance Pro, Medtronic) before and after PVI (20.8±9.1 min after isolation of left PVs with PFA and 20.0±5.1 minute with CBA; P=0.756). All procedures were performed under deep sedation applying propofol and fentanyl.…”
mentioning
confidence: 99%
“… 8 , 10 , 11 , 12 , 13 , 14 , 15 , 16 The other eight were from data presented at conferences and published as abstracts. 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 The sample size for these studies was 485 participants (Supporting Information File).…”
Section: Resultsmentioning
confidence: 99%
“… 24 , 25 One single-centre study reports acute bidirectional block in 84% of anterior lines with a focal PFA tip catheter (standard RF catheters with use of a PFA generator) during a median time of 26 min. 26 Another study reporting on the first commercial use of the lattice-tip catheter with dual energy possibilities, all linear lesions beyond PVI were successfully blocked with PF or the use of PFA combined with RFC, all within a few minutes ablation time (minimal 2 min, maximal 14.7 min). 27 To date, in the largest study, investigating the focal lattice-tip catheter, all 30 roof lines created by PFA with an improved waveform were chronically blocked after evaluation during a three-month invasive remapping EP study, favouring a lattice-tip catheter design for creation of linear PFA lesions.…”
Section: Discussionmentioning
confidence: 99%